Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Other financing activities (2016 - 2019)

Historic Other financing activities for Northwest Biotherapeutics (NWBO) over the last 11 years, with Q4 2019 value amounting to $108000.0.

  • Northwest Biotherapeutics' Other financing activities changed N/A to $108000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $108000.0, marking a year-over-year decrease of 2173.91%. This contributed to the annual value of $108000.0 for FY2019, which is 2173.91% down from last year.
  • Latest data reveals that Northwest Biotherapeutics reported Other financing activities of $108000.0 as of Q4 2019.
  • In the past 5 years, Northwest Biotherapeutics' Other financing activities ranged from a high of $2.6 million in Q3 2017 and a low of -$2.6 million during Q4 2017
  • Over the past 5 years, Northwest Biotherapeutics' median Other financing activities value was $229500.0 (recorded in 2015), while the average stood at $178200.0.
  • Its Other financing activities has fluctuated over the past 5 years, first surged by 1370000.0% in 2015, then plummeted by 89439.25% in 2017.
  • Quarter analysis of 5 years shows Northwest Biotherapeutics' Other financing activities stood at $138000.0 in 2015, then soared by 132.61% to $321000.0 in 2016, then crashed by 894.39% to -$2.6 million in 2017, then surged by 105.41% to $138000.0 in 2018, then fell by 21.74% to $108000.0 in 2019.
  • Its Other financing activities stands at $108000.0 for Q4 2019, versus $138000.0 for Q2 2018 and -$2.6 million for Q4 2017.